This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Vanessa Kress, PhD
Business Development Manager at CEVEC – now part of Cytiva
Speaker

Profile

Vanessa Kress is a Business Development Manager for Cell Line Development Services and Viral Vector Manufacturing technologies. In this global role, she is a point of contact for all clients, ranging from Biotech to Big Pharma, that are ready to go into deeper discussions on the services and business models related to the viral vector technologies offered by Cytiva. Prior to joining Cytiva, she held a Medical Consultant position and worked as a postdoctoral researcher in biochemical neuroscience. Vanessa holds a PhD in Biological Sciences from the University of Cologne, Germany.

Agenda Sessions

  • The next generation of AAV manufacturing combines high scalability with enhanced purity by reducing encapsidated host cell DNA

    12:30